T. Rowe Price Associates’s SYNERGETICS USA, INC. SURG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-18,900
Closed -$124K 2596
2015
Q3
$124K Hold
18,900
﹤0.01% 2383
2015
Q2
$89K Hold
18,900
﹤0.01% 2472
2015
Q1
$102K Hold
18,900
﹤0.01% 2466
2014
Q4
$82K Buy
18,900
+1,000
+6% +$3.59K ﹤0.01% 2486
2014
Q3
$61K Hold
17,900
﹤0.01% 2507
2014
Q2
$55K Hold
17,900
﹤0.01% 2507
2014
Q1
$55K Hold
17,900
﹤0.01% 2475
2013
Q4
$65K Hold
17,900
﹤0.01% 2442
2013
Q3
$81K Hold
17,900
﹤0.01% 2406
2013
Q2
$71K Buy
+17,900
New +$59K ﹤0.01% 2374

T. Rowe Price Associates's SURG Position: Q4 2015 in Review

T. Rowe Price Associates sold out of SYNERGETICS USA, INC. (SURG) in Q4 2015, closing a stake of 18,900 shares — an estimated $124K sold.

T. Rowe Price Associates first reported a position in SURG in Q2 2013 and held it in 10 quarters. The position peaked at $124K in Q3 2015. 0 funds tracked by Wall St. Rank hold SURG as of Q4 2015.

  • T. Rowe Price Associates reported no remaining SYNERGETICS USA, INC. position as of Q4 2015 after selling out during the quarter.
  • T. Rowe Price Associates sold 18,900 SYNERGETICS USA, INC. shares in Q4 2015, an estimated $124K.
  • T. Rowe Price Associates first reported a position in SYNERGETICS USA, INC. in Q2 2013 and held it in 10 quarters.
  • T. Rowe Price Associates's SYNERGETICS USA, INC. position peaked at $124K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held SYNERGETICS USA, INC. as of Q4 2015.

Based on T. Rowe Price Associates's 13F filing for Q4 2015, filed 16 Feb 2016.